137 related articles for article (PubMed ID: 30858147)
21. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.
Gowen M; Stroup GB; Dodds RA; James IE; Votta BJ; Smith BR; Bhatnagar PK; Lago AM; Callahan JF; DelMar EG; Miller MA; Nemeth EF; Fox J
J Clin Invest; 2000 Jun; 105(11):1595-604. PubMed ID: 10841518
[TBL] [Abstract][Full Text] [Related]
22. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
23. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
[TBL] [Abstract][Full Text] [Related]
25. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
[TBL] [Abstract][Full Text] [Related]
26. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
[TBL] [Abstract][Full Text] [Related]
27. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
28. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
30. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
[TBL] [Abstract][Full Text] [Related]
31. Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women.
Tang Y; Xia H; Kang L; Sun Q; Su Z; Hao C; Xue Y
Med Sci Monit; 2019 Jan; 25():259-268. PubMed ID: 30620727
[TBL] [Abstract][Full Text] [Related]
32. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
33. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
34. In the ovariectomized rat, tamoxifen conserves bone similarly in parathyroid-intact and parathyroidectomized animals.
Goulding A; Gold E
Bone; 1994; 15(5):497-503. PubMed ID: 7980960
[TBL] [Abstract][Full Text] [Related]
35. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
36. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
37. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat.
Hodsman AB; Watson PH; Drost D; Holdsworth D; Thornton M; Hock J; Bryant H; Fraher LJ
Bone; 1999 May; 24(5):451-5. PubMed ID: 10321904
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
[TBL] [Abstract][Full Text] [Related]
40. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]